Chothani Foods (540681)

Fast Grower

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹29.43
Market Cap₹32.09 Cr
P/E Ratio58.1
ROCE2.3%
ROE—%
Dividend Yield0%
Profit Growth116.67%
Debt/Equity
Sales Growth21.91%
52-Week Range₹7.9 — ₹46.66
SectorFood Products

Strengths

Concerns

AI Analysis

Let me start with what I like. Chothani Foods sells packaged foods — a business I can understand, and one with a growing middle-class tailwind. Sales are up 21.91%, and reported profit growth is 116.67%. That headline growth catches the eye. But Buffett does not buy headlines; he buys moats and returns on capital. On that test, Chothani comes up short. ROCE is just 2.30%. For every ₹100 employed in this business, it earns barely ₹2.30 — less than a bank deposit and with far more risk. A business earning that return is usually commodity-like, without pricing power or a durable competitive advantage. The latest quarter shows ₹4 crore of sales but ₹0 crore of net profit. Trailing earnings, after backing out the P/E of 58.10 and market cap of ₹32 crore, are only about ₹0.55 crore. A 116% profit jump on an annual base of roughly half a crore is not evidence of lasting growth; it is a small company taking a few steps. The PEG ratio of 0.84 seems attractive, but a PEG built on one high-growth year can mislead. Graham would reject it: no margin of safety. The Piotroski F-Score of 7/9 is a positive sign, and I appreciate that. It tells me operations may be improving. Yet at ₹29.43, the stock is still down from its 52-week high of ₹46.66 and still expensive at 58 times earnings. There is no dividend to support the price while I wait. If Chothani can show sustained positive quarterly profit, move ROCE toward double digits, and grow its quarterly sales beyond ₹4 crore, I would revisit it. But for now, this is a pricey fast grower — a watchlist business, not a compounding machine.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer